Alerts will be sent to your verified email
Verify EmailGUJTERC
|
Guj. Terce Lab
|
Venmax Drugs&Pharma
|
Medicamen Organics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.73 % | 1.17 % | 13.81 % |
|
5yr average Equity Multiplier
|
3.3 | 0.08 | 2.71 |
|
5yr Average Asset Turnover Ratio
|
1.76 | 0.14 | 0.66 |
|
5yr Avg Net Profit Margin
|
-2.57 % | -19.62 % | 8.45 % |
|
Price to Book
|
3.45 | 2.97 | 0.0 |
|
P/E
|
0.0 | 32.22 | 6.32 |
|
5yr Avg Cash Conversion Cycle
|
-20.6 Days | 288.55 Days | -17.75 Days |
|
Inventory Days
|
40.01 Days | 5.2 Days | 81.12 Days |
|
Days Receivable
|
39.02 Days | 430.69 Days | 203.36 Days |
|
Days Payable
|
100.7 Days | 141.12 Days | 289.0 Days |
|
5yr Average Interest Coverage Ratio
|
1.07 | -260.56 | 7.35 |
|
5yr Avg ROCE
|
3.46 % | -47.43 % | 22.44 % |
|
5yr Avg Operating Profit Margin
|
-0.49 % | -65.91 % | 14.84 % |
|
5 yr average Debt to Equity
|
0.63 | -0.45 | 0.85 |
|
5yr CAGR Net Profit
|
-17.21 % | -42.57 % | 33.09 % |
|
5yr Average Return on Assets
|
-3.57 % | 199.45 % | 5.55 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.03 % | 13.8 % | 59.73 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.58 % | -9.33 % | 0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Terce Lab
|
Venmax Drugs&Pharma
|
Medicamen Organics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|